Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
IST:KLKIM.E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
IST:KLKIM.E
|
TR |
|
L3harris Technologies Inc
NYSE:LHX
|
US |
|
Impulse Qingdao Health Tech Co Ltd
SZSE:002899
|
CN |
|
Lum Chang Holdings Ltd
SGX:L19
|
SG |
|
I
|
InventisBio Co Ltd
SSE:688382
|
CN |
|
Foxconn Technology Co Ltd
TWSE:2354
|
TW |
|
Fuji PS Corp
TSE:1848
|
JP |
|
Scotts Miracle-Gro Co
NYSE:SMG
|
US |
|
Beiersdorf AG
XETRA:BEI
|
DE |
|
I
|
Information Planning Co Ltd
TSE:3712
|
JP |
|
Taiwan Fu Hsing Industrial Co Ltd
TWSE:9924
|
TW |
|
D
|
DC Healthcare Holdings Bhd
KLSE:DCHCARE
|
MY |
|
Plby Group Inc
NASDAQ:PLBY
|
US |
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
|
Y
|
Yoma Strategic Holdings Ltd
XBER:O3B
|
SG |
|
H
|
HSBC Holdings PLC
OTC:HBCYF
|
UK |
|
Electrolux Professional AB (publ)
STO:EPRO B
|
SE |
|
Sos Ltd
NYSE:SOS
|
CN |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
CN |
|
S
|
Sepeda Bersama Indonesia Tbk PT
IDX:BIKE
|
ID |
Income Statement
Earnings Waterfall
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
Income Statement
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
13
|
11
|
9
|
9
|
3
|
7
|
12
|
19
|
5
|
29
|
54
|
91
|
174
|
226
|
267
|
299
|
292
|
284
|
0
|
0
|
0
|
|
| Revenue |
526
N/A
|
590
+12%
|
668
+13%
|
711
+6%
|
810
+14%
|
969
+20%
|
1 331
+37%
|
1 683
+26%
|
4 221
+151%
|
4 973
+18%
|
6 238
+25%
|
7 441
+19%
|
4 668
-37%
|
7 267
+56%
|
7 258
0%
|
7 364
+1%
|
9 807
+33%
|
7 702
-21%
|
8 272
+7%
|
9 197
+11%
|
10 696
+16%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(321)
|
(359)
|
(409)
|
(440)
|
(503)
|
(594)
|
(820)
|
(1 061)
|
(2 907)
|
(3 406)
|
(4 169)
|
(4 852)
|
(2 864)
|
(4 435)
|
(4 423)
|
(4 484)
|
(5 859)
|
(4 674)
|
(5 002)
|
(5 540)
|
(6 312)
|
|
| Gross Profit |
206
N/A
|
231
+12%
|
259
+12%
|
272
+5%
|
307
+13%
|
376
+22%
|
511
+36%
|
622
+22%
|
1 314
+111%
|
1 567
+19%
|
2 069
+32%
|
2 589
+25%
|
1 804
-30%
|
2 832
+57%
|
2 835
+0%
|
2 880
+2%
|
3 948
+37%
|
3 028
-23%
|
3 270
+8%
|
3 657
+12%
|
4 385
+20%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(115)
|
(127)
|
(148)
|
(155)
|
(150)
|
(187)
|
(249)
|
(312)
|
(656)
|
(827)
|
(1 055)
|
(1 229)
|
(860)
|
(1 369)
|
(1 465)
|
(1 585)
|
(1 979)
|
(1 871)
|
(2 026)
|
(2 328)
|
(2 156)
|
|
| Selling, General & Administrative |
(104)
|
(113)
|
(134)
|
(140)
|
(158)
|
(176)
|
(235)
|
(290)
|
(635)
|
(763)
|
(963)
|
(1 169)
|
(874)
|
(1 309)
|
(1 356)
|
(1 377)
|
(1 773)
|
(1 493)
|
(1 576)
|
(1 744)
|
(1 945)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
0
|
(3)
|
(1)
|
(3)
|
(1)
|
(2)
|
(19)
|
(17)
|
(28)
|
(31)
|
(30)
|
|
| Depreciation & Amortization |
(10)
|
(12)
|
(13)
|
(13)
|
(14)
|
(15)
|
(16)
|
(17)
|
(52)
|
(76)
|
(98)
|
(120)
|
(59)
|
(118)
|
(122)
|
(127)
|
(159)
|
(137)
|
(144)
|
(161)
|
(171)
|
|
| Other Operating Expenses |
(0)
|
(1)
|
(1)
|
(2)
|
22
|
5
|
2
|
(5)
|
31
|
14
|
8
|
64
|
73
|
62
|
15
|
(80)
|
(28)
|
(224)
|
(279)
|
(394)
|
(10)
|
|
| Operating Income |
90
N/A
|
104
+15%
|
111
+6%
|
116
+5%
|
158
+36%
|
189
+20%
|
263
+39%
|
310
+18%
|
658
+112%
|
740
+13%
|
1 014
+37%
|
1 360
+34%
|
944
-31%
|
1 463
+55%
|
1 370
-6%
|
1 295
-5%
|
1 968
+52%
|
1 157
-41%
|
1 244
+7%
|
1 330
+7%
|
2 228
+68%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
5
|
12
|
20
|
32
|
92
|
126
|
147
|
155
|
165
|
219
|
338
|
339
|
239
|
379
|
286
|
316
|
256
|
488
|
587
|
685
|
256
|
|
| Non-Reccuring Items |
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(54)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
1
|
1
|
(1)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(6)
|
(8)
|
(8)
|
(8)
|
(359)
|
(535)
|
(688)
|
(974)
|
(531)
|
(1 179)
|
(1 098)
|
(973)
|
(645)
|
(476)
|
(525)
|
(550)
|
(626)
|
|
| Pre-Tax Income |
94
N/A
|
115
+23%
|
129
+12%
|
146
+14%
|
242
+65%
|
303
+25%
|
397
+31%
|
452
+14%
|
465
+3%
|
424
-9%
|
665
+57%
|
725
+9%
|
652
-10%
|
664
+2%
|
558
-16%
|
641
+15%
|
1 531
+139%
|
1 171
-23%
|
1 307
+12%
|
1 463
+12%
|
1 805
+23%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(11)
|
(10)
|
(12)
|
(11)
|
(29)
|
(44)
|
(50)
|
(60)
|
(35)
|
(85)
|
(184)
|
(377)
|
(197)
|
(463)
|
(406)
|
(204)
|
(236)
|
(171)
|
(169)
|
(304)
|
(603)
|
|
| Income from Continuing Operations |
82
|
105
|
117
|
136
|
213
|
260
|
347
|
391
|
430
|
340
|
481
|
348
|
455
|
201
|
152
|
437
|
1 295
|
1 000
|
1 137
|
1 158
|
1 202
|
|
| Income to Minority Interest |
1
|
1
|
1
|
1
|
0
|
0
|
(4)
|
(9)
|
(11)
|
(23)
|
(33)
|
(38)
|
(25)
|
(38)
|
(29)
|
(20)
|
(79)
|
(44)
|
(58)
|
(74)
|
(65)
|
|
| Net Income (Common) |
84
N/A
|
106
+27%
|
118
+11%
|
137
+16%
|
213
+56%
|
260
+22%
|
343
+32%
|
382
+12%
|
419
+9%
|
317
-24%
|
448
+41%
|
310
-31%
|
430
+39%
|
163
-62%
|
122
-25%
|
417
+241%
|
1 216
+192%
|
955
-21%
|
1 079
+13%
|
1 084
+0%
|
1 137
+5%
|
|
| EPS (Diluted) |
0.18
N/A
|
0.23
+28%
|
0.26
+13%
|
0.3
+15%
|
0.46
+53%
|
0.56
+22%
|
0.74
+32%
|
0.82
+11%
|
0.91
+11%
|
0.68
-25%
|
0.96
+41%
|
0.66
-31%
|
0.94
+42%
|
0.35
-63%
|
0.27
-23%
|
0.91
+237%
|
2.64
+190%
|
2.07
-22%
|
2.34
+13%
|
2.35
+0%
|
2.47
+5%
|
|